Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat
In high concentrations, homocysteine can increase the risk of heart attacks and strokes since it can damage arterial walls
2013, and FDA's December 2024 review lists the same trial set
(2010) Achilles tendon healing in rats, showing faster collagen fiber organization and improved biomechanical strength
